HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Iron Gate Global Advisors LLC

Iron Gate Global Advisors LLC lowered its position in HealthEquity, Inc. (NASDAQ:HQY) by 6.3% during the third quarter, HoldingsChannel.com reports. The firm owned 25,218 shares of the company’s stock after selling 1,702 shares during the quarter. HealthEquity makes up approximately 0.3% of Iron Gate Global Advisors LLC’s holdings, making the stock its 29th largest holding. Iron Gate Global Advisors LLC’s holdings in HealthEquity were worth $2,064,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. GSA Capital Partners LLP acquired a new stake in HealthEquity in the third quarter worth $638,000. Vaughan Nelson Investment Management L.P. lifted its position in shares of HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock valued at $69,034,000 after purchasing an additional 226,563 shares in the last quarter. Natixis Advisors LLC increased its position in shares of HealthEquity by 29.8% during the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock valued at $17,122,000 after buying an additional 48,009 shares during the period. Oppenheimer Asset Management Inc. lifted its position in HealthEquity by 29.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company’s stock worth $5,535,000 after buying an additional 14,573 shares during the last quarter. Finally, Diversify Wealth Management LLC purchased a new stake in HealthEquity in the second quarter worth about $8,182,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In related news, Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now owns 3,784 shares in the company, valued at $363,642.40. This trade represents a 21.54 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 10,536 shares of company stock valued at $884,517 over the last quarter. 2.20% of the stock is owned by corporate insiders.

HealthEquity Trading Up 0.1 %

Shares of HQY stock opened at $101.66 on Tuesday. The company has a 50 day moving average of $90.61 and a 200-day moving average of $83.02. The firm has a market cap of $8.88 billion, a P/E ratio of 84.72, a PEG ratio of 1.59 and a beta of 0.55. HealthEquity, Inc. has a 12-month low of $62.10 and a 12-month high of $105.82. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The business had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. Sell-side analysts anticipate that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on HQY shares. Royal Bank of Canada restated an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. JMP Securities reaffirmed a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. BTIG Research raised their target price on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. The Goldman Sachs Group initiated coverage on HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Finally, Bank of America increased their price target on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $108.38.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.